Israel has been underestimated for decades, but has become one of the world powers in terms of technology and not satisfied with it, they have selected Amazon and Pfizer, AstraZeneca, Merk and Teva, the most powerful pharmaceutical companies currently globally, to create not one, but ‘The’ LInnovation Laboratory, in order to investigate topics such as digital healthly computational biotechnology. Love us!
The companies will join the Israel Biotechnology Fund and Amazon Web Services (AWS) to “help both early stage entrepreneurs as well as new companies to face the challenges of the health industry ”. The idea is that these companies form a network of laboratories existing as part of the program initiated by la Israel Innovation Authority (IIA).
But do not think that technology companies were chosen for their role in the COVID-19 pandemic, but that they underwent a strictto tender in which National Digital Ministry, selected them as winners. It is intended that the Innovation Laboratory be established in the ‘Rehovot Science Park’ and begin its operations at some point in the 2021.
The budget is not a problem
The best thing is that with him economic stimulus that will be able to develop anything unimaginable and even high-end treatments in incurable diseases as the group of firms has received a franchise operational five years, a government budget of more than nine million dollars and as if that were not enough, the National Digital Ministry, will finance the 85% of the budget total and three million dollars for each startup that joins the lab.
As this laboratory is part of the ‘Bioconvergence Strategy’ promoted by the Innovation Authority during the last year, aimed at establishing a innovated ecosystemry successful in the sector of health. The money, harbanos, is not a problem, so the Israeli authorities will also participate in the operating costs and in the infrastructure installation from the laboratory.
“This past year, it was shown that the healthcare sector is rapidly transitioning towards the development and use of advanced technologies that integrate engineering and biology, which has already led to more accurate results in a shorter time frame. The innovation and the vast experience of the laboratory partners will allow these companies to establish a industry important and pioneer in Israel“Said Aharon Aharon, CEO of Innovation Authority, in a statement retrieved by ‘C-Tech’.
The Middle Eastern country believes that the Innovation Laboratory will allow new companies and researchers to cooperate with organizations health, advance in einnovative studios, build databases and useful knowledgeunique; develop innovative solutions to help healthcare system and in the near future, to be able to collaborate withn other nations andn the same area.
The purpose of the laboratory is to assist in establishment and advance of new startups that develop computational technologies innovative based on artificial intelligence and destined to discover personalized solutions and treatments. The lab will also help its startups develop innovative drugs and treatments. The rapid development of vaccines for the COVID-19 virus owes its success in part to the Artificial Intelligence (AI) capabilities of leading pharmaceutical companies such as Pfizer and Moderna. These areas are expected to be even more significant in the coming years.